Dr. Martens (LON:DOCS) Insider Giles Wilson Acquires 167 Shares of Stock

Dr. Martens plc (LON:DOCS) insider Giles Wilson bought 167 shares of the stock in a transaction that occurred on Thursday, September 11th. The shares were purchased at an average price of GBX 90 per share, with a total value of £150.30.

Giles Wilson also recently made the following trade(s):

• On Monday, September 1st, Giles Wilson bought 105,838 shares of Dr. Martens stock. The shares were purchased at an average price of GBX 91 per share, with a total value of £96,312.58.
• On Monday, September 1st, Giles Wilson sold 30,000 shares of Dr. Martens stock. The stock was sold at an average price of GBX 91, for a total transaction of £27,300.
• On Monday, September 1st, Giles Wilson bought 30,019 shares of Dr. Martens stock. The shares were purchased at an average price of GBX 91 per share, with a total value of £27,317.29.
• On Monday, September 1st, Giles Wilson sold 105,785 shares of Dr. Martens stock. The stock was sold at an average price of GBX 90, for a total transaction of £95,206.50.
• On Monday, August 11th, Giles Wilson bought 194 shares of Dr. Martens stock. The shares were purchased at an average price of GBX 77 per share, with a total value of £149.38.
• On Friday, July 11th, Giles Wilson acquired 194 shares of Dr. Martens stock. The stock was bought at an average price of GBX 77 per share, with a total value of £149.38.

Dr. Martens Stock Performance

LON DOCS opened at GBX 91.48 on Wednesday. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. Dr. Martens plc has a 1 year low of GBX 43.02 and a 1 year high of GBX 96.50. The company has a market capitalization of £883.39 million, a PE ratio of 18,296.00, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a fifty day moving average of GBX 83.58 and a two-hundred day moving average of GBX 68.31.

Analyst Ratings Changes

Several equities analysts have issued reports on DOCS shares. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Dr. Martens in a research note on Friday, July 11th. Peel Hunt upgraded shares of Dr. Martens to a “buy” rating in a research note on Monday, August 18th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of GBX 6,000.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.